New digital collaboration to back connected medical technologies

Latest News

Companies working to improve health outcomes for patients via digital and connected medical technologies have a new support organisation following the launch of ANDHealth – a national initiative funded through the MTPConnect Project Fund Program.

Established by a consortium of commercial partners, including AusBiotech and the Murdoch Children’s Research Institute, with the support MTPConnect, ANDHealth has been established to facilitate and support the development and commercialisation of clinically validated digital health technologies across Australia.

It will be chaired by former AusBiotech CEO, Dr Anna Lavelle.

According to Bronwyn Le Grice, Managing Director of ANDHealth, “The promise of connected healthcare is enormous and Australia has a proven track record in developing technologies and companies that utilise digital technology to disrupt and transform patient centred care.

“ANDHealth has been created to foster innovation and commercialisation in this space by working with mid-stage digital health projects on proof of concept and pivotal clinical trials and validation, investment readiness and market entry - with a specific focus on regulated digital health technologies which have a clear impact on clinical outcomes for patients.”

Sue Macleman, CEO of MTPConnect, said, “ANDHealth, and the 13 other projects funded through the MTPConnect Project Fund Program, bring together a wide variety of stakeholders to collaboratively and creatively address barriers in the sector. It is through important, nationally focused initiatives such as ANDHealth that the Australian medical technology, biotechnology and pharmaceutical sector will be able to realise its full potential as a world-leader and have major impact.”

ANDhealth will be expanding its team over the coming months and will be running a one day digital health summit in conjunction with AusBiotech on 23 May 23.